Terrence C. Dahl,Munir A. Hussain,Robert A. Lipper,Robert L. Jerzewski,Mark M. Menning,Reza Oliyai,Taiyin Yang
申请号：
US14640825
公开号：
US09545414B2
申请日:
2015.03.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.
